S. Ananth Karumanchi
S. Ananth Karumanchi
Cedars-Sinai Medical Center; Beth Israel Deaconess Medical Center, Harvard Medical School
Verified email at
Cited by
Cited by
Excess Placental Soluble fms-like Tyrosine Kinase 1 (sFlt1) Could Contribute to Endothelial Dysfunction, Hypertension, and Proteinuria in Preeclampsia
SE Maynard, JY Min, J Merchan, KH Lim, J Li, S Mondal, TA Libermann, ...
The Journal of clinical investigation 111 (5), 649-658, 2003
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine, SE Maynard, C Qian, KH Lim, LJ England, KF Yu, ...
New England journal of medicine 350 (7), 672-683, 2004
Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice
MA Brown, LA Magee, LC Kenny, SA Karumanchi, FP McCarthy, S Saito, ...
Hypertension 72 (1), 24-43, 2018
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
RJ Levine, C Lam, C Qian, KF Yu, SE Maynard, BP Sachs, BM Sibai, ...
New England Journal of Medicine 355 (10), 992-1005, 2006
Soluble endoglin contributes to the pathogenesis of preeclampsia
S Venkatesha, M Toporsian, C Lam, J Hanai, T Mammoto, YM Kim, ...
Nature medicine 12 (6), 642-649, 2006
Preeclampsia: pathophysiology, challenges, and perspectives
S Rana, E Lemoine, JP Granger, SA Karumanchi
Circulation research 124 (7), 1094-1112, 2019
Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease
CE Powe, RJ Levine, SA Karumanchi
Circulation 123 (24), 2856-2869, 2011
Vitamin D–binding protein and vitamin D status of black Americans and white Americans
CE Powe, MK Evans, J Wenger, AB Zonderman, AH Berg, M Nalls, ...
New England Journal of Medicine 369 (21), 1991-2000, 2013
Pre-eclampsia: pathogenesis, novel diagnostics and therapies
EA Phipps, R Thadhani, T Benzing, SA Karumanchi
Nature Reviews Nephrology 15 (5), 275-289, 2019
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
C Wei, S El Hindi, J Li, A Fornoni, N Goes, J Sageshima, D Maiguel, ...
Nature medicine 17 (8), 952-960, 2011
Pathogenesis of preeclampsia
BC Young, RJ Levine, SA Karumanchi
Annual Review of Pathology: Mechanisms of Disease 5, 173-192, 2010
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal …
R Romero, JK Nien, J Espinoza, D Todem, W Fu, H Chung, JP Kusanovic, ...
The journal of maternal-fetal & neonatal medicine 21 (1), 9-23, 2008
Preeclampsia: the role of angiogenic factors in its pathogenesis
A Wang, S Rana, SA Karumanchi
Physiology 24 (3), 147-158, 2009
Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia
S Rana, CE Powe, S Salahuddin, S Verlohren, FH Perschel, RJ Levine, ...
Circulation 125 (7), 911-919, 2012
Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia
C Lam, KH Lim, SA Karumanchi
Hypertension 46 (5), 1077-1085, 2005
Angiogenic factors and preeclampsia
SE Maynard, SA Karumanchi
Seminars in nephrology 31 (1), 33-46, 2011
First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia
R Thadhani, WP Mutter, M Wolf, RJ Levine, RN Taylor, VP Sukhatme, ...
The Journal of Clinical Endocrinology & Metabolism 89 (2), 770-775, 2004
Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans
SM Parikh, T Mammoto, A Schultz, HT Yuan, D Christiani, SA Karumanchi, ...
PLoS medicine 3 (3), e46, 2006
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy
IS Patten, S Rana, S Shahul, GC Rowe, C Jang, L Liu, MR Hacker, ...
Nature 485 (7398), 333-338, 2012
Molecular mechanisms of preeclampsia
WP Mutter, SA Karumanchi
Microvascular research 75 (1), 1-8, 2008
The system can't perform the operation now. Try again later.
Articles 1–20